Document:

Employment Agreement, Andrew Reynolds

 Exhibit 10.12 
 EMPLOYMENT AGREEMENT 
 This Employment Agreement (the
“Agreement”) is entered into as of June     , 2011 (the “Effective Date”) by and between FleetMatics Group Limited (the “Company”), FleetMatics USA, LLC, 70 Walnut Park, 2nd floor, Wellesley Hills, MA 02481 (“U.S.
Subsidiary”) and Andrew Reynolds of [            ] (“Executive”). The parties hereby agree as follows: 

1. Description: 
 The Executive shall initially serve as the Senior Vice President of Business Development. The Executive shall initially report to, take direction from and assume such duties and responsibilities
consistent with his position as are assigned to him by the chief executive officer of the Company (the “CEO”) or such other person designated by the CEO or the Board of Directors of the Company (the “Board”) from
time to time. The Executive shall devote his full working time and efforts to the business and affairs of the Company. Notwithstanding the foregoing, Executive may participate in (a) civic and charitable activities, (b) the management of
Executive’s family and personal affairs, including his investments, and (c) other business activities approved in writing by the CEO (which approval shall not be unreasonably withheld) and serving as a member of non-profit and for-profit
boards of directors, so long as such activities (i) do not interfere with the performance of Executive’s duties to the Company, and (ii) do not create a conflict of interest with the U.S. Subsidiary or the Company. 

(a) Obligations. During Executive’s employment he will not engage in any other employment, occupations or consulting activity
for any direct or indirect remuneration for any activity that would create a conflict of interest between Executive and U.S. Subsidiary or the Company, without the prior approval of the Board. 

(b) Employment. U.S. Subsidiary will employ Executive on the terms and conditions set forth herein. Executive will receive his
cash compensation and benefits from U.S. Subsidiary and U.S. Subsidiary will maintain and distribute employment-related records. The payment and performance of U.S. Subsidiary’s obligations under this Agreement is a joint and several obligation
of U.S. Subsidiary and the Company. 
 2. At-Will Employment. Subject to the severance provisions set forth in
Section 7 below, the parties agree that Executive’s employment with U.S. Subsidiary will be “at-will” employment and may be terminated at any time with or without cause or notice subject to the terms of this Agreement. Executive
understands and agrees that neither his job performance nor promotions, commendations, bonuses or the like from the Company or U.S. Subsidiary give rise to or in any way serve as the basis for modification, amendment, or extension, by implication or
otherwise, of his at-will employment status with the U.S. Subsidiary. 

 3. Compensation. 

(a) Base Salary. Executive’s initial base salary shall be paid at the rate of $250,000 (two hundred and fifty-thousand
dollars) per year, payable bi-weekly in accordance with U.S. Subsidiary’s normal payroll practices and be subject to the usual, required deductions and withholdings. Executive’s base salary will be subject to review based upon the U.S.
Subsidiary’s normal performance review practices. The annual base salary in effect at any given time is referred to herein as “Base Salary.” 
 (b) Annual Bonus. Executive will be eligible to earn a bonus at an annual target of 50% (fifty percent) of Base Salary, less applicable withholding taxes, based on the achievement of corporate
objectives to be determined by the Board, and personal performance objectives to be determined by the Board after consultation with the Executive. The Executive’s target, performance objectives and the achievement of those objectives shall be
determined in the sole discretion of the Board or the Compensation Committee of the Board, and where applicable, based on financial and other calculable results of the Company. The annual bonus in effect at any given time is referred to herein as
the “Annual Bonus”. Except as otherwise provided herein, to earn any part of the Annual Bonus, the Executive must be employed by the U.S. Subsidiary on December 31 of the applicable bonus year. The 2011 Annual Bonus will be
pro-rated based on Executive’s period of employment. Any Annual Bonus shall be paid between January 1 and March 15 of the year following the year in which such Annual Bonus is earned. 

(c) Stock Options. The Company shall recommend to the Board for approval a grant to Executive of stock options to acquire 154,000
Ordinary Shares pursuant to the terms of the Company’s stock option program. Such stock options shall vest over a four (4) year vesting schedule with 25% vesting on the one-year anniversary of Executive’s date of hire and the
remaining 75% vesting in 3 equal annual installments over the following three (3) years following such anniversary. The Company shall recommend to the Board for approval a grant to Executive of stock options to acquire 66,000 Ordinary Shares
pursuant to the terms of the Company’s stock option program. Such stock options shall vest subject to performance-based vesting conditions mutually agreed to by Executive and the chief executive officer and approved by the Board. 

4. Employee Benefits. During his employment, Executive will be entitled to participate in the employee benefit plans currently and
hereafter maintained by the U.S. Subsidiary of general applicability to other senior executives of the U.S. Subsidiary residing in the United States of America. The U.S. Subsidiary will provide one hundred percent (100%) of the cost of Health,
Dental and Vision benefit. The Company and U.S. Subsidiary reserves the right to cancel or change the benefit plans and programs it offers to its employees at any time. 
 5. Vacation. Executive will be entitled to paid vacation of four (4) weeks per year, accrued on a pro rata basis in accordance with U.S. Subsidiary’s vacation policy. 

6. Expenses. U.S. Subsidiary will reimburse Executive for reasonable travel, entertainment or other expenses incurred by Executive
in the furtherance of or in connection with the performance of Executive’s duties hereunder, in accordance with U.S. Subsidiary’s expense reimbursement policy as in effect from time to time. 

  
 2 

 7. Termination/Severance. Except as otherwise provided below, if Executive’s
employment with the U.S. Subsidiary terminates for any reason, then (i) all vesting will terminate immediately with respect to Executive’s outstanding stock options not yet vested, (ii) all payments of compensation by the Company or
U.S. Subsidiary to Executive hereunder will terminate immediately (except as to Base Salary earned through the last day of employment and Annual Bonus amounts already earned but not yet paid for the prior calendar year, if any). In addition, the
following terms shall apply depending on the circumstances of the Executive’s termination: 
 (a) Termination Without
Cause or Resignation for Good Reason Apart from a Change of Control. If prior to or absent a Change of Control, (i) the U.S. Subsidiary terminates Executive’s employment without Cause or (ii) Executive resigns from employment for
Good Reason, then, subject to Section 8, Executive will be entitled to: (A) receive continuing payments of severance pay at a rate equal to his monthly Base Salary rate, as then in effect, for six (6) months; and (B) Company-paid
coverage for Executive and Executive’s eligible dependents under U.S. Subsidiary’s Benefit Plans for six (6) months following such termination. 
 (b) Termination Without Cause or Resignation for Good Reason within Six (6) Months after a Change of Control. If (i) within six (6) months after a Change of Control the U.S.
Subsidiary terminates Executive’s employment with the U.S. Subsidiary without Cause, or (ii) Executive resigns from employment for Good Reason, then, subject to Section 8, Executive will be entitled to: (A) receive continuing
payments of severance pay at a rate equal to his monthly Base Salary rate, as then in effect, for twelve (12) months; (B) Company-paid coverage for Executive and Executive’s eligible dependents under U.S. Subsidiary’s Benefit
Plans for twelve (12) months following such termination or resignation and (C) 100% of any outstanding stock options not yet vested shall become immediately vested upon Executive’s date of termination or resignation. 

(c) Termination for Cause: Resignation without Good Reason. If Executive’s employment with the U.S. Subsidiary terminates
voluntarily by Executive (except upon resignation for Good Reason), or for Cause by the Company, then (i) all vesting will terminate immediately with respect to Executive’s outstanding stock options not yet vested, (ii) all payments
of compensation by the Company or U.S. Subsidiary to Executive hereunder will terminate immediately (except as to Base Salary earned through the last day of employment and Annual Bonus amounts already earned but not yet paid for the prior calendar
year, if any), and (iii) Executive will be eligible for severance benefits in accordance with the U.S. Subsidiary’s established policies, if any, as then in effect. 
 (d) Termination Upon Death or Disability. If Executive’s employment terminates due to Executive’s death or disability, then (i) all payments of compensation by the Company or U.S.
Subsidiary to Executive hereunder will terminate immediately (except as to salary through the last day of employment and Annual Bonus amounts already earned, if any), (ii) Executive will only be eligible for severance benefits in accordance
with the Company’s established policies, if any, as then in effect, and (iii) in addition to the number of shares of stock options that have vested as of the date of such termination pursuant to the schedule set forth in Section 3(c),
a number of shares of stock options will vest equal to the number of shares of stock options that would have otherwise vested if Executive had remained employed with the U.S. 

  
 3 

 
Subsidiary through the six-month anniversary of the Effective Date immediately following the date of such termination. For the purposes of this Agreement, Executive’s employment may be
terminated as a result of disability if Executive is disabled and unable to perform the essential functions of the Executive’s then existing position or positions under this Agreement with or without reasonable accommodation for a period of 120
days (which need not be consecutive) in any 12-month period. If any question shall arise as to whether during any period Executive is disabled so as to be unable to perform the essential functions of Executive’s then existing position or
positions with or without reasonable accommodation, the Executive may, and at the request of the Company shall, submit to the Company a certification in reasonable detail by a physician selected by the Company to whom the Executive or the
Executive’s guardian has no reasonable objection as to whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the purposes of this Agreement be conclusive of the issue.
Notwithstanding the foregoing, such certification shall not be used to circumvent or reduce the time period of 120 days in any 12 month period. The Executive shall cooperate with any reasonable request of the physician in connection with such
certification. If such question shall arise and the Executive shall fail to submit such certification within fifteen (15) days following a formal request by the Company, the Company’s determination of such issue shall be binding on the
Executive. Nothing in this Section 7(d) shall be construed to waive the Executive’s rights, if any, under existing law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et seq. and the
Americans with Disabilities Act, 42 U.S.C. §12101 et seq. 
 8. Receipt of Severance: No Duty to Mitigate.

 (a) Separation Agreement/Commencement of Severance Pay. The receipt of any severance pursuant to Section 7 will
be subject to Executive signing and not revoking a release agreement in favor of the Company and related persons and entities in a form and manner satisfactory to the Company (the “Release”) and the expiration of the seven-day
revocation period for the Release, within 60 days following the Date of Termination. No severance will be paid or provided unless the release agreement becomes fully effective. The severance shall be paid out in substantially equal installments in
accordance with the Company’s payroll practice over twelve (12) months commencing within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year,
the severance shall begin to be paid in the second calendar year. Solely for purposes of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), each installment payment is considered a separate payment.

 (b) Noncompete/Nonsolicitation. The receipt of any severance pursuant to Section 7 will be subject to Executive
not violating the Non-Competition Agreement referenced in Section 10 of this Agreement and attached hereto as Exhibit A, the terms of which are hereby incorporated by reference. In the event Executive breaches the Non-Competition Agreement the
Company shall have the right to terminate or suspend all continuing payments and benefits to which Executive may otherwise be entitled pursuant to Section 7 without affecting the Executive’s release or Executive’s obligations under
the release agreement. 

  
 4 

 (c) No Duty to Mitigate. Executive will not be required to mitigate the amount of any
severance payment contemplated by this Agreement, nor will any earnings that Executive may receive from any other source reduce any such severance payment. 
 9. Definitions. 
 (a) Benefit Plans. For purposes of this Agreement,
“Benefit Plans” means plans, policies or arrangements that the Company and/or U.S. Subsidiary sponsors (or participates in) and that immediately prior to Executive’s termination of employment provide Executive and/or
Executive’s eligible dependents with medical, dental, and/or vision benefits. Benefit Plans do not include any other type of benefit (including, but not by way of limitation, disability, life insurance or retirement benefits). A requirement
that the Company provide Executive and Executive’s eligible dependents with coverage under the Benefit Plans will be satisfied if the coverage is not materially less favorable than that provided to senior executives of the Company or U.S.
Subsidiary that reside in the United States of America at any applicable time during the period Executive is entitled to receive severance pursuant to Section 7(a) or (b). At the Executive’s option, the Company may satisfy any requirement
that the Company provide coverage under any Benefit Plan by (i) reimbursing Executive’s premiums under Title X of the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”) after Executive has properly
elected continuation coverage under COBRA (in which case Executive will be solely responsible for electing such coverage for his eligible dependents), or (ii) providing coverage under a separate plan or plans providing coverage that is not
materially less favorable or by paying Executive a lump sum payment which is, on an after-tax basis, sufficient to provide Executive and Executive’s eligible dependents with substantially equivalent coverage under a third party plan that is
reasonably available to Executive and Executive’s eligible dependents. If the Company elects to make the lump sum payment provided for under Section 9(a)(ii) to satisfy the Company’s obligations under Section 7(a) or (b), such
payment shall be made upon the release agreement required by Section 8(a) becoming effective (or, if later, the date of Executive’s without Cause termination or, if applicable, Good Reason resignation). 

(b) Cause. For purposes of this Agreement, “Cause” is defined as (i) a proven act of dishonesty made by
Executive in connection with Executive’s responsibilities as an employee that results in proven material injury to the Company, (ii) Executive’s conviction of, or plea of nolo contendere to, a felony or any crime involving
fraud, embezzlement or any other act of moral turpitude, (iii) Executive’s proven gross misconduct that results in proven material injury to the Company, (iv) Executive’s proven unauthorized use or disclosure of any proprietary
information or trade secrets of the Company or any other party to whom Executive owes an obligation of nondisclosure as a result of Executive’s relationship with the Company; (v) Executive’s proven willful breach of any material
obligations under any material written agreement or covenant with the Company; or (vi) Executive’s continued failure to substantially perform his material employment duties after Executive has received a written demand of performance from
the Company which specifically sets forth the factual basis for the Company’s belief that Executive has not substantially performed his material duties and has failed to cure such non-performance to the Company’s satisfaction within
fifteen (15) business days after receiving such notice. 

  
 5 

 (c) Change of Control. For purposes of this Agreement, “Change of
Control” of the Company is defined as: 
 (i) any “person” (as such term is used in Sections
13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) who is not a shareholder of the Company as of the date of this Agreement or an affiliate thereof is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said
Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities; or 

(ii) a change in the composition of the Board occurring within a two-year period, as a result of which less than a
majority of the directors are Incumbent Directors. “Incumbent Directors” will mean directors who either (A) are directors of the Company as of the date hereof, or (B) are elected, or nominated for election, to the Board
with the affirmative votes of at least a majority of the remaining Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection with an actual or threatened proxy
contest relating to the election of directors to the Company); or 
 (iii) the date of the consummation of a
merger, scheme of arrangement or consolidation of the Company with any other corporation that has been approved by the stockholders of the Company, other than a merger, scheme of arrangement or consolidation which would result in the voting
securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the total voting
power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or 
 (iv) the date of the consummation of the sale or disposition by the Company of all or substantially all the Company’s assets. 
 Notwithstanding the foregoing, a transaction will not constitute a Change in Control if: (i) its sole purpose is to change the state of the Company’s incorporation; or (ii) its sole purpose
is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction. 

(d) Good Reason. For the purposes of this Agreement, “Good Reason” means without Executive’s express written
consent, any of the following “Good Reason Conditions”: (i) the Company and/or the U.S. Subsidiary commits a material breach of this Agreement which is not remedied by the Company and/or the U.S. Subsidiary within fifteen
(15) days of receiving written notice from Executive that specifically sets forth the factual basis for Executive’s belief that a material breach has occurred; (ii) a diminution of Executive’s Base Salary of more than 10%
(provided that for purposes of Section 7(b) only, a diminution of Executive’s Base Salary of less than 10% other than in connection with an across-the-board salary reduction affecting all senior executives of the U.S. Subsidiary shall give
rise to a Good 

  
 6 

 
Reason Condition); (iii) a material change in the geographic location at which the Executive provides services to the Company and/or the U.S. Subsidiary (provided that for this purpose, in
no event shall a relocation of such provision of services to a new location less than fifty (50) miles from the current location of the provision of services give rise to a Good Reason Condition); (iv) a material diminution in the
Executive’s responsibilities, authority or duties or (v) a successor to the Company fails to assume this Agreement in writing upon becoming a successor or assignee of the Company. With respect to each of the Good Reason Conditions
described above, Executive may not establish “Good Reason” unless he has provided written notice of the existence of such condition to the Company within 30 days of the event constituting such Good Reason, the Company fails to reasonably
cure such condition within the 15-day period immediately following receipt of such notice and the Executive terminates his employment within sixty (60) days after providing written notice of the existence of a Good Reason Condition or end of
the cure period, whichever is later. 
 10. Confidential Information/Restrictive Covenants. Executive agrees to enter
into the Company’s standard Non-Competition, Confidentiality and Assignment Agreement (the “Non-Competition Agreement”) upon commencing employment hereunder, attached hereto as Exhibit A and the terms of which are hereby
incorporated by reference as material terms of this Agreement. 
 11. Assignment. This Agreement will be binding upon and
inure to the benefit any successor of the Company and any successor of a U.S. subsidiary. Any such successor or affiliate of the Company and any U.S. subsidiary will be deemed substituted for the Company or a U.S. subsidiary, respectively, under the
terms of this Agreement for all purposes. For this purpose “successor” means any person, firm, corporation or other business entity which at any time, whether by purchase, merger, scheme of arrangement or otherwise, directly or indirectly
acquires all or substantially all of the assets or business of either or both the Company or U.S. subsidiary. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred
except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance or other disposition of Executive’s right to compensation or other benefits will be null and void. This Agreement shall be binding upon
and inure to the benefit of Executive and, with respect to Section 7(d), Executive’s legal representatives or heirs. 

12. Notices. All notices, requests, demands and other communications called for hereunder will be in writing and will be deemed
given (i) on the date of delivery if delivered personally, (ii) two (2) business days after the business day of deposit with Federal Express or a similar courier for next business day (or, internationally, second business day)
delivery, or (iii) seven (7) days after being mailed by registered or certified mail, return receipt requested, prepaid and addressed to the parties or their successors at the following addresses, or at such other addresses as the parties
may later designate in writing: 
  

	
	If to the Company:
	
	 FleetMatics USA, LLC
 70 Walnut
Park

2nd floor,

  
 7 

	
	 Wellesley Hills
 MA
02481
 Attn:    Chief Executive Officer, Jim Travers

	
	 With a copy to:
  

Goodwin Procter LLP
 Exchange Place

53 State Street
 Boston, MA 02109

Fax: (617) 523-1231
 Attention: Joseph C.
Theis, Jr., Esq.
 Email: jtheis@goodwinprocter.com

	
	 If to Executive:
  

[                    ]

 13. Severability. In the event that any provision hereof becomes or is declared by a court of
competent jurisdiction to be illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision. 
 14. Arbitration. To ensure the rapid and economical resolution of disputes that may arise in connection with Executive’s employment with the Company or U.S. Subsidiary, Executive and the
Company agree that any and all disputes, claims, or causes of action, in law or equity, arising from or relating to the enforcement, breach, performance, or interpretation of this Agreement, Executive’s employment, or the termination of
Executive’s employment, shall be resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration in Boston, Massachusetts, conducted by the Judicial Arbitration and Mediation Services, Inc.
(“JAMS”) or its successor, under the then applicable rules of JAMS. Executive and the Company acknowledge that by agreeing to this arbitration procedure, each party waives the right to resolve any such dispute through a trial by
jury or judge or administrative proceeding. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a
written arbitration decision including the arbitrator’s essential findings and conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that Executive or the Company would be entitled to seek in
a court of law. Nothing in this Agreement is intended to prevent either the Executive or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. 

Notwithstanding the foregoing, Executive and the Company each have the right to petition the court for injunctive relief and seek damages relating to any
issue or dispute arising under the Non-Competition Agreement. 

  
 8 

 15. Integration. This Agreement, and the Non-Competition Agreement represents the
entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral, provided however, the stock options referenced in Section 3(c) shall be
governed by the applicable stock option plans and agreements (in conjunction with the terms as modified herein). This Agreement may be modified only by agreement of the parties by a written instrument executed by the parties that is designated as an
amendment to this Agreement. 
 16. Waiver of Breach. The waiver of a breach of any term or provision of this Agreement,
which must be in writing, will not operate as or be construed to be a waiver of any other previous or subsequent breach of this Agreement. 
 17. Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement. 

18. Tax Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable taxes. 

19. Governing Law/Consent to Jurisdiction. This Agreement will be governed by the laws of the Commonwealth of Massachusetts (with
the exception of its conflict of laws provisions). The parties hereby expressly consent to the personal jurisdiction of the state and federal courts located in the Commonwealth of Massachusetts for any action or proceeding arising from or relating
to this Agreement and/or relating to any arbitration in which the parties are participants. The parties hereby agree that the state and federal courts in Commonwealth of Massachusetts shall have the exclusive jurisdiction to consider any matters
related to this Agreement, including without limitation any claim for violation of this Agreement. With respect to any such court action, the Executive (i) submits to the jurisdiction of such courts, (ii) consents to service of process,
and (iii) waives any other requirement (whether imposed by statute, rule of court or otherwise) with respect to personal jurisdiction or venue. 
 20. Acknowledgment. Executive acknowledges that he has had the opportunity to discuss this matter with and obtain advice from his private attorney, has had sufficient time to, and has carefully
read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement. 

21. Counterparts. This Agreement may be executed in counterparts, and each counterpart will have the same force and effect as an
original and will constitute an effective, binding agreement on the part of each of the undersigned. 
 22. Attorney’s
Fees. In the event of a dispute between the parties under this Agreement, the prevailing party shall be entitled to recover its costs and attorney’s fees from the non-prevailing party, including those incurred at trial, arbitration, and on
appeal. 
 23. 409A. Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive’s
separation from service within the meaning of Section 409A of the Code, the Company determines that the Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any
payment or benefit that the Executive becomes entitled to under this Agreement on account of the Executive’s separation from service 

  
 9 

 
would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of
Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one day after the Executive’s separation from service, or
(B) the Executive’s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period
but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule. All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided
by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the
taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible
for reimbursement in any other taxable year. Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit. To the extent that any payment or benefit described in this Agreement constitutes
“non-qualified deferred compensation” under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive’s termination of employment, then such payments or benefits shall be payable only
upon the Executive’s “separation from service.” The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h).
The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision
shall be read in such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with
Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party. The Company makes no representation or warranty and shall have no
liability to the Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.

  
 10 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	The Company
	
	FleetMatics Group Limited
		
	By:	 	  

		 	Name:
		 	Title:
	
	U.S. Subsidiary
	
	FleetMatics USA, LLC
		
	By:	 	  

		 	Name:
		 	Title:
	
	The Executive
		
	By:	 	  

  
 11 

 EXHIBIT A 

FleetMatics USA, LLC 
 Employee Non-Competition, Confidentiality and Assignment Agreement 
 In
consideration and as a material condition of my employment by FleetMatics USA, LLC, a subsidiary of FleetMatics Group Limited (collectively the “Company”), I agree as follows: 

 

 1. Proprietary Information. I agree that all information, whether or not in
writing, concerning the Company’s business, technology, business relationships or financial affairs which the Company has not released to the general public (collectively, “Proprietary Information”) is and will be the exclusive
property of the Company. By way of illustration, Proprietary Information may include information or material which has not been made generally available to the public, such as: (a) corporate information, including plans, strategies,
methods, policies, resolutions, negotiations or litigation; (b) marketing information, including strategies, methods, customer identities or other information about customers, prospect identities or other information about prospects, or
market analyses or projections; (c) financial information, including cost and performance data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists; and (d) operational and
technological information, including plans, specifications, manuals, forms, templates, software, designs, methods, procedures, formulas, discoveries, inventions, improvements, concepts and ideas; and (e) personnel information,
including personnel lists, reporting or organizational structure, resumes, personnel data, compensation structure, performance evaluations and termination arrangements or documents. Proprietary Information also includes information received in
confidence by the Company from its customers or suppliers or other third parties. 
 2. Recognition of Company’s
Rights. I will not, at any time, without the Company’s prior written permission, either during or after my employment, disclose any Proprietary Information to anyone outside of the Company, or use or permit to be used any Proprietary
Information for any purpose other than in connection with the performance of my duties as an employee of the Company. I will cooperate with the Company and use my best efforts to prevent the unauthorized disclosure of all Proprietary Information. I
will deliver to the Company all copies of Proprietary Information in my possession or control upon the earlier of a request by the Company or termination of my employment. 
 3. Rights of Others. I understand that the Company is now and may hereafter be subject to non-disclosure or confidentiality agreements with third persons which require the Company to protect
or refrain from use of proprietary information. I agree to be bound by the terms of such of those agreements as to which I have knowledge in the event I have access to such proprietary information.

 4. Commitment to Company; Avoidance of Conflict of Interest. Subject to the
express terms of my employment agreement with the Company, while an employee of the Company, I will devote my full-time efforts to the Company’s business and I will not engage in any other business activity that conflicts with my duties to the
Company. I will advise the president of the Company or his or her nominee at such time as any activity of either the Company or another business presents me with a conflict of interest or the appearance of a conflict of interest as an employee of
the Company. I will take whatever action is requested of me by the Company to resolve any conflict or appearance of conflict which it finds to exist. 
 5. Developments. I will make full and prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms,
databases, computer programs, formulae, techniques, trade secrets, graphics or images, and audio or visual works and other works of authorship related to the business of the Company (collectively “Developments”), whether or not patentable
or copyrightable, that are created, made, conceived or reduced to practice by me (alone or jointly with others) or under my direction during the period of my employment. I acknowledge that all work performed by me for the Company is on a “work
for hire” basis, and I hereby do assign and transfer and, to the extent any such assignment cannot be made at present, will assign and transfer, to the Company and its successors and assigns all my right, title and interest in all Developments
made, conceived or reduced to practice by me (alone or jointly with others) that (a) relate to the business of the Company or any customer of or supplier to the Company or any of the products or services being researched, developed,
manufactured or sold by the Company or which may be used with such products or services; or (b) result from tasks assigned to me by the Company; or (c) result from the use of premises or personal property (whether tangible or intangible)
owned, leased or contracted for by the Company (“Company-Related Developments”), and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, and other intellectual property
rights in all countries and territories worldwide and under any international conventions (“Intellectual Property Rights”). 
 To
preclude any possible uncertainty, I have set forth on Exhibit 1 attached hereto a complete list of Developments that I have, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of my employment
with the Company that I consider to be my property or the property of third parties and that I wish to have

 

 
excluded from the scope of this Agreement (“Prior Inventions”). If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I understand
that I am not to list such Prior Inventions in Exhibit 1 but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made
for that reason. I have also listed on Exhibit A all patents and patent applications in which I am named as an inventor, other than those which have been assigned to the Company (“Other Patent Rights”). If no such disclosure is
attached, I represent that there are no Prior Inventions or Other Patent Rights. If, in the course of my employment with the Company, I incorporate a Prior Invention into a Company product, process or machine or other work done for the Company, I
hereby grant to the Company a nonexclusive, royalty-free, paid-up, irrevocable, worldwide license (with the full right to sublicense) to make, have made, modify, use, sell, offer for sale and import such Prior Invention. Notwithstanding the
foregoing, I will not incorporate, or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company’s prior written consent. 
 This Agreement does not obligate me to assign to the Company any Development which, in the sole judgment of the Company, reasonably exercised, is developed entirely on my own time and does not relate to
the business efforts or research and development efforts in which, during the period of my employment, the Company actually is engaged or reasonably would be engaged, and does not result from the use of premises or equipment owned or leased by the
Company. However, I will also promptly disclose to the Company any such Developments for the purpose of determining whether they qualify for such exclusion. I understand that to the extent this Agreement is required to be construed in accordance
with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this paragraph 5 will be interpreted not to apply to any invention which a court rules and/or the Company
agrees falls within such classes. I also hereby waive all claims to any moral rights or other special rights which I may have or accrue in any Company-Related Developments. 
 6. Documents and Other Materials. I will keep and maintain adequate and current records of all Proprietary Information and Company-Related Developments developed by me during my employment,
which records will be available to and remain the sole property of the Company at all times. 
 All files, letters, notes, memoranda, reports,
records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, program listings, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary
Information, whether created by me or others, which come into my custody or possession, are the exclusive property of the Company to be used by me only in the performance of my duties for the Company. Any property situated on the Company’s
premises

 
and owned by the Company, including without limitation computers, disks and other storage media, filing cabinets or other work areas, is subject to inspection by the Company at any time with or
without notice. In the event of the termination of my employment for any reason, I will deliver to the Company all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals,
specification sheets, program listings, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary Information, and other materials of any nature pertaining to the Proprietary Information
of the Company and to my work, and will not take or keep in my possession any of the foregoing or any copies. 
 7.
Enforcement of Intellectual Property Rights. I will cooperate fully with the Company, both during and after my employment with the Company, with respect to the procurement, maintenance and enforcement of Intellectual Property Rights in
Company-Related Developments. I will sign, both during and after the term of this Agreement, all papers, including without limitation copyright applications, patent applications, declarations, oaths, assignments of priority rights, and powers of
attorney, which the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development. If the Company is unable, after reasonable effort, to secure my signature on any such papers, I hereby
irrevocably designate and appoint each officer of the Company as my agent and attorney-in-fact to execute any such papers on my behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect its rights and
interests in any Company-Related Development. 
 8. Non-Competition and Non-Solicitation. In order to protect
the Company’s Proprietary Information and good will, during my employment and for a period of twelve (12) months following the termination of my employment for any reason (the “Restricted Period”), I will not directly or
indirectly, whether as owner, partner, shareholder, director, manager, consultant, agent, employee, co-venturer or otherwise, engage, participate or invest in any business activity anywhere in the United States that (i) is engaged in the sale,
installation or distribution of GPS Vehicle Tracking Systems then engaged in by the Company, and/or (ii) develops, manufactures or markets any products, or performs any services, that are otherwise competitive with the products or services of
the Company, or products or services that the Company or its affiliates, has under development or that are the subject of active planning at any time during my employment (8(i) and (ii) shall be referred to as the “Company’s
Business”); provided that this shall not prohibit any possible investment in publicly traded stock of a company representing less than one percent of the stock of such company. In addition, during the Restricted Period, I will not, directly or
indirectly, in any manner, other than for the benefit of the Company, (a) call upon, solicit, divert, take away, accept or conduct any business from or with any of the customers or prospective customers of the Company or any of its suppliers if
such activities in competition with the 

 

  
 2 

 
Company’s Business, and/or (b) solicit, entice, attempt to persuade any other employee or consultant of the Company to leave the Company for any reason or otherwise participate in or
facilitate the hire, directly or through another entity, of any person who is employed or engaged by the Company or who was employed or engaged by the Company within six months of any attempt to hire such person. I acknowledge and agree that if I
violate any of the provisions of this paragraph 8, the running of the Restricted Period will be extended by the time during which I engage in such violation(s). For purposes of this Agreement, a “prospective customer” means any potential
customer of the Company which I knew or reasonably should have known that the Company was actively soliciting (other than through a general campaign) or actively considered soliciting (other than through a general campaign) at any time within the
twelve (12) calendar months prior to the last day of my employment. 
 9. Prior Agreements. I hereby
represent that, except as I have fully disclosed previously in writing to the Company, I am not bound by the terms of any agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential or
proprietary information in the course of my employment with the Company or to refrain from competing, directly or indirectly, with the business of such previous employer or any other party. I further represent that my performance of all the terms of
this Agreement as an employee of the Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by me in confidence or in trust prior to my employment with the Company. I will not
disclose to the Company or induce the Company to use any confidential or proprietary information or material belonging to any previous employer or others. 
 10. Remedies Upon Breach. I understand that the restrictions contained in this Agreement are necessary for the protection of the business and goodwill of the Company and I consider them to
be reasonable for such purpose. Any breach of this Agreement is likely to cause the Company substantial and irrevocable damage and therefore, in the event of such breach, the Company, in addition to such other remedies which may be available, will
be entitled to specific performance and other injunctive relief, without the posting of a bond. If I violate this Agreement, in addition to all other remedies available to the Company at law, in equity, and under contract, I agree that I am
obligated to pay all the Company’s costs of enforcement of this Agreement, including attorneys’ fees and expenses. 

11. Use of Voice, Image and Likeness. I give the Company permission to use any and all of my voice, image and likeness,
with or without using my name, in connection with the products and/or services of the Company, for the purposes of advertising and promoting such products and/or services and/or the Company, and/or for other purposes deemed appropriate by the
Company in its reasonable discretion, except to the extent expressly prohibited by law.

 12. Publications and Public Statements. I will obtain the Company’s
written approval before publishing or submitting for publication any material that relates to my work at the Company and/or incorporates any Proprietary Information. To ensure that the Company delivers a consistent message about its products,
services and operations to the public, and further in recognition that even positive statements may have a detrimental effect on the Company in certain securities transactions and other contexts, any statement about the Company which I create,
publish or post during my period of employment and for six (6) months thereafter, on any media accessible by the public, including but not limited to electronic bulletin boards and Internet-based chat rooms, must first be reviewed and approved
by an officer of the Company before it is released in the public domain. 
 13. No Employment Obligation. I
understand that this Agreement does not create an obligation on the Company or any other person to continue my employment. I acknowledge that, unless otherwise agreed in a formal written employment agreement signed on behalf of the Company by an
authorized officer, my employment with the Company is at will and therefore may be terminated by the Company or me at any time and for any reason, with or without cause. 
 14. Survival and Assignment by the Company. I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title,
position, duties, salary, compensation or benefits or other terms and conditions of employment. I further understand that my obligations under this Agreement will continue following the termination of my employment regardless of the manner of such
termination and will be binding upon my heirs, executors and administrators. The Company will have the right to assign this Agreement to its affiliates, successors and assigns. I expressly consent to be bound by the provisions of this Agreement for
the benefit of the Company or any parent, subsidiary or affiliate to whose employ I may be transferred or successor who assumes my employment agreement with the Company without the necessity that this Agreement be resigned at the time of such
transfer or assumption. 
 15. Exit Interview. If and when I depart from the Company, I may be required to
attend an exit interview and sign an “Employee Exit Acknowledgement” to reaffirm my acceptance and acknowledgement of the obligations set forth in this Agreement. For twelve (12) months following termination of my employment, I will
notify the Company of any change in my address and of each subsequent employment or business activity, including the name and address of my employer or other post-Company employment plans and the nature of my activities. 

16. Disclosure to Future Employers. During the Restricted Period, I will provide a copy of this Agreement to any
prospective employer, partner or coventurer prior to entering into an employment, partnership or other business relationship with such person or entity.

 

  
 3 

 17. Severability. In case any provisions (or portions thereof) contained in
this Agreement shall, for any reason, be held invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such
invalid, illegal or unenforceable provision had never been contained herein. If, moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope,
activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear. 
 18. Interpretation. This Agreement will be deemed to be made and entered into in the Commonwealth of Massachusetts, and will in all respects be interpreted, enforced and governed under the
laws of the Commonwealth of Massachusetts. I hereby agree to consent to personal jurisdiction of the state and federal courts situated within Suffolk County, Massachusetts for purposes of enforcing this Agreement, and waive any objection that I
might have to personal jurisdiction or venue in those courts.

  

 

  
 4 

 I UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. BY SIGNING BELOW, I CERTIFY
THAT I HAVE READ IT CAREFULLY AND AM SATISFIED THAT I UNDERSTAND IT COMPLETELY. 
 IN WITNESS WHEREOF, the undersigned has
executed this agreement as a sealed instrument as of the date set forth below. 
  

			
	Signed:	 	  

			
		
	Type or print name:	 	  

			
		
	Date:	 	  

 EXHIBIT 1 

 

			
	To:	 	FleetMatics USA, LLC
		
	From:	 	

			
		
	Date:	 	

			
		
	SUBJECT:	 	Prior Inventions

 The following is a complete list of all inventions or improvements relevant to the subject matter of my
employment by the Company that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company: 
 No inventions or improvements 
 See below: 

 

	
	  

	
	  

	
	  

 Additional sheets attached 
 The following is a list of all patents and patent applications in which I have been named as an inventor: 
 None 
 See below: 

 

	
	  

	
	  

	
	  

  
 6Employment Agreement, Karen Leavitt

 Exhibit 10.13 
 EMPLOYMENT AGREEMENT 
 This Employment Agreement (the
“Agreement”) is entered into as of January 4, 2012 (the “Effective Date”) by and between FleetMatics Group Limited (the “Company”), FleetMatics USA, LLC, 70 Walnut Park, 2nd floor, Wellesley Hills, MA 02481 (“U.S.
Subsidiary”) and Karen Leavitt of 30 Abbottswood, Sudbury, Ma 01776 (“Executive”). The parties hereby agree as follows: 
 1. Description: 
 The Executive shall initially serve as the Chief
Marketing Officer. The Executive shall initially report to, take direction from and assume such duties and responsibilities consistent with her position as are assigned to her by the chief executive officer of the Company (the
“CEO”) or such other person designated by the CEO or the Board of Directors of the Company (the “Board”) from time to time. The Executive shall devote her full working time and efforts to the business and affairs of
the Company. Notwithstanding the foregoing, Executive may participate in (a) civic and charitable activities, (b) the management of Executive’s family and personal affairs, including her investments, and (c) other business
activities approved in writing by the CEO (which approval shall not be unreasonably withheld) and serving as a member of non-profit and for-profit boards of directors, so long as such activities (i) do not interfere with the performance of
Executive’s duties to the Company, and (ii) do not create a conflict of interest with the U.S. Subsidiary or the Company. 
 (a) Obligations. During Executive’s employment she will not engage in any other employment, occupations or consulting activity for any direct or indirect remuneration for any activity that
would create a conflict of interest between Executive and U.S. Subsidiary or the Company, without the prior approval of the Board. 
 (b) Employment. U.S. Subsidiary will employ Executive on the terms and conditions set forth herein. Executive will receive her cash compensation and benefits from U.S. Subsidiary and U.S.
Subsidiary will maintain and distribute employment-related records. The payment and performance of U.S. Subsidiary’s obligations under this Agreement is a joint and several obligation of U.S. Subsidiary and the Company. 

2. At-Will Employment. Subject to the severance provisions set forth in Section 7 below, the parties agree that
Executive’s employment with U.S. Subsidiary will be “at-will” employment and may be terminated at any time with or without cause or notice subject to the terms of this Agreement. Executive understands and agrees that neither her job
performance nor promotions, commendations, bonuses or the like from the Company or U.S. Subsidiary give rise to or in any way serve as the basis for modification, amendment, or extension, by implication or otherwise, of her at-will employment status
with the U.S. Subsidiary. 

 3. Compensation. 

(a) Base Salary. Executive’s initial base salary shall be paid at the rate of $250,000 (two hundred and fifty-thousand
dollars) per year, payable bi-weekly in accordance with U.S. Subsidiary’s normal payroll practices and be subject to the usual, required deductions and withholdings. Executive’s base salary will be subject to review based upon the U.S.
Subsidiary’s normal performance review practices. The annual base salary in effect at any given time is referred to herein as “Base Salary.” 
 (b) Annual Bonus. Executive will be eligible to earn a bonus at an annual target of 50% (fifty percent) of Base Salary, less applicable withholding taxes, based on the achievement of corporate
objectives to be determined by the Board, and personal performance objectives to be determined by the Board after consultation with the Executive. The Executive’s target, performance objectives and the achievement of those objectives shall be
determined in the sole discretion of the Board or the Compensation Committee of the Board, and where applicable, based on financial and other calculable results of the Company. The annual bonus in effect at any given time is referred to herein as
the “Annual Bonus”. Except as otherwise provided herein, to earn any part of the Annual Bonus, the Executive must be employed by the U.S. Subsidiary on December 31 of the applicable bonus year. Any Annual Bonus shall be paid
between January 1 and March 15 of the year following the year in which such Annual Bonus is earned. 
 (c) Stock
Options. The Company shall recommend to the Board for approval a grant to Executive of stock options to acquire 150,000 Ordinary Shares pursuant to the terms of the Company’s stock option program. 105,000 of such stock options shall vest
over a four (4) year vesting schedule with 25% vesting on the one-year anniversary of Executive’s date of hire and the remaining 75% vesting in twelve (12) equal installments over the following twelve (12) three-calendar month
periods following such anniversary. 45,000 of such stock options shall vest subject to performance-based vesting conditions approved by the Board. 
 4. Employee Benefits. During her employment, Executive will be entitled to participate in the employee benefit plans currently and hereafter maintained by the U.S. Subsidiary of general
applicability to other senior executives of the U.S. Subsidiary residing in the United States of America. The U.S. Subsidiary will provide one hundred percent (100%) of the cost of Health, Dental and Vision benefit. The Company and U.S.
Subsidiary reserves the right to cancel or change the benefit plans and programs it offers to its employees at any time. 
 5.
Vacation. Executive will be entitled to paid vacation of four (4) weeks per year, accrued on a pro rata basis in accordance with U.S. Subsidiary’s vacation policy. 

6. Expenses. U.S. Subsidiary will reimburse Executive for reasonable travel, entertainment or other expenses incurred by Executive
in the furtherance of or in connection with the performance of Executive’s duties hereunder, in accordance with U.S. Subsidiary’s expense reimbursement policy as in effect from time to time. 

7. Termination/Severance. Except as otherwise provided below, if Executive’s employment with the U.S. Subsidiary terminates
for any reason, then (i) all vesting will terminate immediately with respect to Executive’s outstanding stock options not yet vested, (ii) all payments of compensation by the Company or U.S. Subsidiary to Executive hereunder

  
 2 

 
will terminate immediately (except as to Base Salary earned through the last day of employment and Annual Bonus amounts already earned but not yet paid for the prior calendar year, if any). In
addition, the following terms shall apply depending on the circumstances of the Executive’s termination: 
 (a)
Termination Without Cause or Resignation for Good Reason Apart from a Change of Control. If prior to or absent a Change of Control, (i) the U.S. Subsidiary terminates Executive’s employment without Cause or (ii) Executive
resigns from employment for Good Reason, then, subject to Section 8, Executive will be entitled to: (A) receive continuing payments of severance pay at a rate equal to her monthly Base Salary rate, as then in effect, for six
(6) months; and (B) if the Executive was participating in the Company’s group health plan immediately prior to the date of termination, then the Company shall pay to the Executive in a single lump sum cash payment equal to six
(6) months of monthly employer contribution that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company. 

(b) Termination Without Cause or Resignation for Good Reason within Six (6) Months after a Change of Control. If
(i) within six (6) months after a Change of Control the U.S. Subsidiary terminates Executive’s employment with the U.S. Subsidiary without Cause, or (ii) Executive resigns from employment for Good Reason, then, subject to
Section 8, Executive will be entitled to: (A) receive continuing payments of severance pay at a rate equal to her monthly Base Salary rate, as then in effect, for twelve (12) months; (B) if the Executive was participating in the
Company’s group health plan immediately prior to the date of termination, then the Company shall pay to the Executive in a single lump sum cash payment equal to twelve (12) months equal to the amount of monthly employer contribution that
the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company and (C) 100% of any outstanding stock options not yet vested shall become immediately vested upon Executive’s
date of termination or resignation. 
 (c) Termination for Cause: Resignation without Good Reason. If Executive’s
employment with the U.S. Subsidiary terminates voluntarily by Executive (except upon resignation for Good Reason), or for Cause by the Company, then (i) all vesting will terminate immediately with respect to Executive’s outstanding stock
options not yet vested, (ii) all payments of compensation by the Company or U.S. Subsidiary to Executive hereunder will terminate immediately (except as to Base Salary earned through the last day of employment and Annual Bonus amounts already
earned but not yet paid for the prior calendar year, if any), and (iii) Executive will be eligible for severance benefits in accordance with the U.S. Subsidiary’s established policies, if any, as then in effect. 

(d) Termination Upon Death or Disability. If Executive’s employment terminates due to Executive’s death or disability,
then (i) all payments of compensation by the Company or U.S. Subsidiary to Executive hereunder will terminate immediately (except as to salary through the last day of employment and Annual Bonus amounts already earned, if any),
(ii) Executive will only be eligible for severance benefits in accordance with the Company’s established policies, if any, as then in effect, and (iii) in addition to the number of shares of stock options that have vested as of the
date of such termination pursuant to the schedule set forth in Section 3(c), a number of shares of stock options will vest equal to the number of shares of stock 

  
 3 

 
options that would have otherwise vested if Executive had remained employed with the U.S. Subsidiary through the six-month anniversary of the Effective Date immediately following the date of such
termination. For the purposes of this Agreement, Executive’s employment may be terminated as a result of disability if Executive is disabled and unable to perform the essential functions of the Executive’s then existing position or
positions under this Agreement with or without reasonable accommodation for a period of 120 days (which need not be consecutive) in any 12-month period. If any question shall arise as to whether during any period Executive is disabled so as to be
unable to perform the essential functions of Executive’s then existing position or positions with or without reasonable accommodation, the Executive may, and at the request of the Company shall, submit to the Company a certification in
reasonable detail by a physician selected by the Company to whom the Executive or the Executive’s guardian has no reasonable objection as to whether the Executive is so disabled or how long such disability is expected to continue, and such
certification shall for the purposes of this Agreement be conclusive of the issue. Notwithstanding the foregoing, such certification shall not be used to circumvent or reduce the time period of 120 days in any 12 month period. The Executive shall
cooperate with any reasonable request of the physician in connection with such certification. If such question shall arise and the Executive shall fail to submit such certification within fifteen (15) days following a formal request by the
Company, the Company’s determination of such issue shall be binding on the Executive. Nothing in this Section 7(d) shall be construed to waive the Executive’s rights, if any, under existing law including, without limitation, the
Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et seq. and the Americans with Disabilities Act, 42 U.S.C. §12101 et seq. 
 8. Receipt of Severance: No Duty to Mitigate. 
 (a) Separation
Agreement/Commencement of Severance Pay. The receipt of any severance pursuant to Section 7 will be subject to Executive signing and not revoking a release agreement in favor of the Company and related persons and entities in a form
reasonably required by the Company (the “Release”) and the expiration of the seven-day revocation period for the Release, within 60 days following the Date of Termination. No severance will be paid or provided unless the release
agreement becomes fully effective. The severance shall be paid out in substantially equal installments in accordance with the Company’s payroll practice over, in the case of severance paid pursuant to Section 7(a), six (6) months, or
in the case of severance paid pursuant to Section 7(b), twelve (12) months, in each case commencing within 60 days after the Date of Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second
calendar year, the severance shall begin to be paid in the second calendar year. Solely for purposes of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), each installment payment is considered a
separate payment. 
 (b) Noncompete/Nonsolicitation. The receipt of any severance pursuant to Section 7 will be
subject to Executive not violating the Non-Competition Agreement referenced in Section 10 of this Agreement and attached hereto as Exhibit A, the terms of which are hereby incorporated by reference. In the event Executive breaches the
Non-Competition Agreement the Company shall have the right to terminate or suspend all continuing payments and benefits to which Executive may otherwise be entitled pursuant to Section 7 without affecting the Executive’s release or
Executive’s obligations under the release agreement. 

  
 4 

 (c) No Duty to Mitigate. Executive will not be required to mitigate the amount of any
severance payment contemplated by this Agreement, nor will any earnings that Executive may receive from any other source reduce any such severance payment. 
 9. Definitions. 
 (a) Benefit Plans. For purposes of this Agreement,
“Benefit Plans” means plans, policies or arrangements that the Company and/or U.S. Subsidiary sponsors (or participates in) and that immediately prior to Executive’s termination of employment provide Executive and/or
Executive’s eligible dependents with medical, dental, and/or vision benefits. Benefit Plans do not include any other type of benefit (including, but not by way of limitation, disability, life insurance or retirement benefits). A requirement
that the Company provide Executive and Executive’s eligible dependents with coverage under the Benefit Plans will be satisfied if the coverage is not materially less favorable than that provided to senior executives of the Company or U.S.
Subsidiary that reside in the United States of America at any applicable time during the period Executive is entitled to receive severance pursuant to Section 7(a) or (b). At the Executive’s option, the Company may satisfy any requirement
that the Company provide coverage under any Benefit Plan by (i) reimbursing Executive’s premiums under Title X of the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”) after Executive has properly
elected continuation coverage under COBRA (in which case Executive will be solely responsible for electing such coverage for her eligible dependents), or (ii) providing coverage under a separate plan or plans providing coverage that is not
materially less favorable or by paying Executive a lump sum payment which is, on an after-tax basis, sufficient to provide Executive and Executive’s eligible dependents with substantially equivalent coverage under a third party plan that is
reasonably available to Executive and Executive’s eligible dependents. If the Company elects to make the lump sum payment provided for under Section 9(a)(ii) to satisfy the Company’s obligations under Section 7(a) or (b), such
payment shall be made upon the release agreement required by Section 8(a) becoming effective (or, if later, the date of Executive’s without Cause termination or, if applicable, Good Reason resignation). 

(b) Cause. For purposes of this Agreement, “Cause” is defined as (i) a proven act of dishonesty made by
Executive in connection with Executive’s responsibilities as an employee that results in proven material injury to the Company, (ii) Executive’s conviction of, or plea of nolo contendere to, a felony or any crime involving
fraud, embezzlement or any other act of moral turpitude, (iii) Executive’s proven gross misconduct that results in proven material injury to the Company, (iv) Executive’s proven unauthorized use or disclosure of any proprietary
information or trade secrets of the Company or any other party to whom Executive owes an obligation of nondisclosure as a result of Executive’s relationship with the Company; (v) Executive’s proven willful breach of any material
obligations under any material written agreement or covenant with the Company; or (vi) Executive’s continued failure to substantially perform her material employment duties after Executive has received a written demand of performance from
the Company which specifically sets forth the factual basis for the Company’s belief that Executive has not substantially performed her material duties and has failed to cure such non-performance to the Company’s satisfaction within
fifteen (15) business days after receiving such notice. 

  
 5 

 (c) Change of Control. For purposes of this Agreement, “Change of
Control” of the Company is defined as: 
 (i) any “person” (as such term is used in Sections
13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) who is not a shareholder of the Company as of the date of this Agreement or an affiliate thereof is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said
Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities; or 

(ii) a change in the composition of the Board occurring within a two-year period, as a result of which less than a
majority of the directors are Incumbent Directors. “Incumbent Directors” will mean directors who either (A) are directors of the Company as of the date hereof, or (B) are elected, or nominated for election, to the Board
with the affirmative votes of at least a majority of the remaining Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection with an actual or threatened proxy
contest relating to the election of directors to the Company); or 
 (iii) the date of the consummation of a
merger, scheme of arrangement or consolidation of the Company with any other corporation that has been approved by the stockholders of the Company, other than a merger, scheme of arrangement or consolidation which would result in the voting
securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the total voting
power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or 
 (iv) the date of the consummation of the sale or disposition by the Company of all or substantially all the Company’s assets. 
 Notwithstanding the foregoing, a transaction will not constitute a Change in Control if: (i) its sole purpose is to change the state of the Company’s incorporation; or (ii) its sole purpose
is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction. 

(d) Good Reason. For the purposes of this Agreement, “Good Reason” means without Executive’s express written
consent, any of the following “Good Reason Conditions”: (i) the Company and/or the U.S. Subsidiary commits a material breach of this Agreement which is not remedied by the Company and/or the U.S. Subsidiary within fifteen
(15) days of receiving written notice from Executive that specifically sets forth the factual basis for Executive’s belief that a material breach has occurred; (ii) a diminution of Executive’s Base Salary of more than 10%
(provided that for purposes of Section 7(b) only, a diminution of Executive’s Base Salary of less than 10% other than in connection with an across-the-board salary reduction affecting all senior executives of the U.S. Subsidiary shall give
rise to a Good 

  
 6 

 
Reason Condition); (iii) a material change in the geographic location at which the Executive provides services to the Company and/or the U.S. Subsidiary (provided that for this purpose, in
no event shall a relocation of such provision of services to a new location less than fifty (50) miles from the current location of the provision of services give rise to a Good Reason Condition); (iv) a material diminution in the
Executive’s responsibilities, authority or duties or (v) a successor to the Company fails to assume this Agreement in writing upon becoming a successor or assignee of the Company. With respect to each of the Good Reason Conditions
described above, Executive may not establish “Good Reason” unless she has provided written notice of the existence of such condition to the Company within 30 days of the event constituting such Good Reason, the Company fails to reasonably
cure such condition within the 15-day period immediately following receipt of such notice and the Executive terminates her employment within sixty (60) days after providing written notice of the existence of a Good Reason Condition or end of
the cure period, whichever is later. 
 10. Confidential Information/Restrictive Covenants. Executive agrees to enter
into the Company’s standard Non-Competition, Confidentiality and Assignment Agreement (the “Non-Competition Agreement”) upon commencing employment hereunder, attached hereto as Exhibit A and the terms of which are hereby
incorporated by reference as material terms of this Agreement. 
 11. Assignment. This Agreement will be binding upon and
inure to the benefit any successor of the Company and any successor of a U.S. subsidiary. Any such successor or affiliate of the Company and any U.S. subsidiary will be deemed substituted for the Company or a U.S. subsidiary, respectively, under the
terms of this Agreement for all purposes. For this purpose “successor” means any person, firm, corporation or other business entity which at any time, whether by purchase, merger, scheme of arrangement or otherwise, directly or indirectly
acquires all or substantially all of the assets or business of either or both the Company or U.S. subsidiary. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred
except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance or other disposition of Executive’s right to compensation or other benefits will be null and void. This Agreement shall be binding upon
and inure to the benefit of Executive and, with respect to Section 7(d), Executive’s legal representatives or heirs. 

12. Notices. All notices, requests, demands and other communications called for hereunder will be in writing and will be deemed
given (i) on the date of delivery if delivered personally, (ii) two (2) business days after the business day of deposit with Federal Express or a similar courier for next business day (or, internationally, second business day)
delivery, or (iii) seven (7) days after being mailed by registered or certified mail, return receipt requested, prepaid and addressed to the parties or their successors at the following addresses, or at such other addresses as the parties
may later designate in writing: 
 If to the Company: 
 FleetMatics USA, LLC 
 70 Walnut Park 

2nd floor, 

  
 7 

 Wellesley Hills 
 MA 02481 
 Attn: Chief Executive Officer, Jim Travers 

With a copy to: 

Goodwin Procter LLP 
 Exchange Place 
 53 State Street 

Boston, MA 02109 

Fax: (617) 523-1231 
 Attention: Joseph C. Theis, Jr., Esq. 
 Email: jtheis@goodwinprocter.com

 If to Executive: 
 30 Abbottswood 
 Sudbury, Ma 01776 

13. Severability. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be
illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision. 
 14.
Arbitration. To ensure the rapid and economical resolution of disputes that may arise in connection with Executive’s employment with the Company or U.S. Subsidiary, Executive and the Company agree that any and all disputes, claims, or
causes of action, in law or equity, arising from or relating to the enforcement, breach, performance, or interpretation of this Agreement, Executive’s employment, or the termination of Executive’s employment, shall be resolved, to the
fullest extent permitted by law, by final, binding and confidential arbitration in Boston, Massachusetts, conducted by the Judicial Arbitration and Mediation Services, Inc. (“JAMS”) or its successor, under the then applicable rules
of JAMS. Executive and the Company acknowledge that by agreeing to this arbitration procedure, each party waives the right to resolve any such dispute through a trial by jury or judge or administrative proceeding. The arbitrator shall: (a) have
the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision including the arbitrator’s essential findings and
conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that Executive or the Company would be entitled to seek in a court of law. Nothing in this Agreement is intended to prevent either the
Executive or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. 

Notwithstanding the foregoing, Executive and the Company each have the right to petition the court for injunctive relief and seek damages relating to any
issue or dispute arising under the Non-Competition Agreement. 

  
 8 

 15. Integration. This Agreement, and the Non-Competition Agreement represents the
entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral, provided however, the stock options referenced in Section 3(c) shall be
governed by the applicable stock option plans and agreements (in conjunction with the terms as modified herein). This Agreement may be modified only by agreement of the parties by a written instrument executed by the parties that is designated as an
amendment to this Agreement. 
 16. Waiver of Breach. The waiver of a breach of any term or provision of this Agreement,
which must be in writing, will not operate as or be construed to be a waiver of any other previous or subsequent breach of this Agreement. 
 17. Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement. 

18. Tax Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable taxes. 

19. Governing Law/Consent to Jurisdiction. This Agreement will be governed by the laws of the Commonwealth of Massachusetts (with
the exception of its conflict of laws provisions). The parties hereby expressly consent to the personal jurisdiction of the state and federal courts located in the Commonwealth of Massachusetts for any action or proceeding arising from or relating
to this Agreement and/or relating to any arbitration in which the parties are participants. The parties hereby agree that the state and federal courts in Commonwealth of Massachusetts shall have the exclusive jurisdiction to consider any matters
related to this Agreement, including without limitation any claim for violation of this Agreement. With respect to any such court action, the Executive (i) submits to the jurisdiction of such courts, (ii) consents to service of process,
and (iii) waives any other requirement (whether imposed by statute, rule of court or otherwise) with respect to personal jurisdiction or venue. 
 20. Acknowledgment. Executive acknowledges that she has had the opportunity to discuss this matter with and obtain advice from her private attorney, has had sufficient time to, and has carefully
read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement. 

21. Counterparts. This Agreement may be executed in counterparts, and each counterpart will have the same force and effect as an
original and will constitute an effective, binding agreement on the part of each of the undersigned. 
 22. Attorney’s
Fees. In the event of a dispute between the parties under this Agreement, the prevailing party shall be entitled to recover its costs and attorney’s fees from the non-prevailing party, including those incurred at trial, arbitration, and on
appeal. 
 23. 409A. Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive’s
separation from service within the meaning of Section 409A of the Code, the Company determines that the Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any
payment or benefit that the Executive becomes entitled to under this Agreement on account of the Executive’s separation from service 

  
 9 

 
would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of
Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one day after the Executive’s separation from service, or
(B) the Executive’s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period
but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule. All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided
by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the
taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible
for reimbursement in any other taxable year. Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit. To the extent that any payment or benefit described in this Agreement constitutes
“non-qualified deferred compensation” under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive’s termination of employment, then such payments or benefits shall be payable only
upon the Executive’s “separation from service.” The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h).
The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision
shall be read in such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with
Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party. The Company makes no representation or warranty and shall have no
liability to the Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.

  
 10 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	The Company
	
	FleetMatics Group Limited
		
	By:	 	  

		 	Name:
		 	Title:
	
	U.S. Subsidiary
	
	FleetMatics USA, LLC
		
	By:	 	  

		 	Name:
		 	Title:
	
	The Executive
		
	By:	 	  

  
 11 

 EXHIBIT A 

FleetMatics USA, LLC 
 Employee Non-Competition, Confidentiality and Assignment Agreement 
 In
consideration and as a material condition of my employment by FleetMatics USA, LLC, a subsidiary of FleetMatics Group Limited (collectively the “Company”), I agree as follows: 

 

 1. Proprietary Information. I agree that all information, whether or not in
writing, concerning the Company’s business, technology, business relationships or financial affairs which the Company has not released to the general public (collectively, “Proprietary Information”) is and will be the exclusive
property of the Company. By way of illustration, Proprietary Information may include information or material which has not been made generally available to the public, such as: (a) corporate information, including plans, strategies,
methods, policies, resolutions, negotiations or litigation; (b) marketing information, including strategies, methods, customer identities or other information about customers, prospect identities or other information about prospects, or
market analyses or projections; (c) financial information, including cost and performance data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists; and (d) operational and
technological information, including plans, specifications, manuals, forms, templates, software, designs, methods, procedures, formulas, discoveries, inventions, improvements, concepts and ideas; and (e) personnel information,
including personnel lists, reporting or organizational structure, resumes, personnel data, compensation structure, performance evaluations and termination arrangements or documents. Proprietary Information also includes information received in
confidence by the Company from its customers or suppliers or other third parties. 
 2. Recognition of Company’s
Rights. I will not, at any time, without the Company’s prior written permission, either during or after my employment, disclose any Proprietary Information to anyone outside of the Company, or use or permit to be used any Proprietary
Information for any purpose other than in connection with the performance of my duties as an employee of the Company. I will cooperate with the Company and use my best efforts to prevent the unauthorized disclosure of all Proprietary Information. I
will deliver to the Company all copies of Proprietary Information in my possession or control upon the earlier of a request by the Company or termination of my employment. 
 3. Rights of Others. I understand that the Company is now and may hereafter be subject to non-disclosure or confidentiality agreements with third persons which require the Company to protect
or refrain from use of proprietary information. I agree to be bound by the terms of such of those agreements as to which I have knowledge in the event I have access to such proprietary information.

 4. Commitment to Company; Avoidance of Conflict of Interest. Subject to the
express terms of my employment agreement with the Company, while an employee of the Company, I will devote my full-time efforts to the Company’s business and I will not engage in any other business activity that conflicts with my duties to the
Company. I will advise the president of the Company or his or her nominee at such time as any activity of either the Company or another business presents me with a conflict of interest or the appearance of a conflict of interest as an employee of
the Company. I will take whatever action is requested of me by the Company to resolve any conflict or appearance of conflict which it finds to exist. 
 5. Developments. I will make full and prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms,
databases, computer programs, formulae, techniques, trade secrets, graphics or images, and audio or visual works and other works of authorship related to the business of the Company (collectively “Developments”), whether or not patentable
or copyrightable, that are created, made, conceived or reduced to practice by me (alone or jointly with others) or under my direction during the period of my employment. I acknowledge that all work performed by me for the Company is on a “work
for hire” basis, and I hereby do assign and transfer and, to the extent any such assignment cannot be made at present, will assign and transfer, to the Company and its successors and assigns all my right, title and interest in all Developments
made, conceived or reduced to practice by me (alone or jointly with others) that (a) relate to the business of the Company or any customer of or supplier to the Company or any of the products or services being researched, developed,
manufactured or sold by the Company or which may be used with such products or services; or (b) result from tasks assigned to me by the Company; or (c) result from the use of premises or personal property (whether tangible or intangible)
owned, leased or contracted for by the Company (“Company-Related Developments”), and all related patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, and other intellectual property
rights in all countries and territories worldwide and under any international conventions (“Intellectual Property Rights”). 
 To
preclude any possible uncertainty, I have set forth on Exhibit 1 attached hereto a complete list of Developments that I have, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of my employment
with the Company that I consider to be my property or the property of third parties and that I wish to have

 

 
excluded from the scope of this Agreement (“Prior Inventions”). If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I understand
that I am not to list such Prior Inventions in Exhibit 1 but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been
made for that reason. I have also listed on Exhibit A all patents and patent applications in which I am named as an inventor, other than those which have been assigned to the Company (“Other Patent Rights”). If no such disclosure is
attached, I represent that there are no Prior Inventions or Other Patent Rights. If, in the course of my employment with the Company, I incorporate a Prior Invention into a Company product, process or machine or other work done for the Company, I
hereby grant to the Company a nonexclusive, royalty-free, paid-up, irrevocable, worldwide license (with the full right to sublicense) to make, have made, modify, use, sell, offer for sale and import such Prior Invention. Notwithstanding the
foregoing, I will not incorporate, or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company’s prior written consent. 
 This Agreement does not obligate me to assign to the Company any Development which, in the sole judgment of the Company, reasonably exercised, is developed entirely on my own time and does not relate to
the business efforts or research and development efforts in which, during the period of my employment, the Company actually is engaged or reasonably would be engaged, and does not result from the use of premises or equipment owned or leased by the
Company. However, I will also promptly disclose to the Company any such Developments for the purpose of determining whether they qualify for such exclusion. I understand that to the extent this Agreement is required to be construed in accordance
with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this paragraph 5 will be interpreted not to apply to any invention which a court rules and/or the Company
agrees falls within such classes. I also hereby waive all claims to any moral rights or other special rights which I may have or accrue in any Company-Related Developments. 
 6. Documents and Other Materials. I will keep and maintain adequate and current records of all Proprietary Information and Company-Related Developments developed by me during my employment,
which records will be available to and remain the sole property of the Company at all times. 
 All files, letters, notes, memoranda, reports,
records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, program listings, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary
Information, whether created by me or others, which come into my custody or possession, are the exclusive property of the Company to be used by me only in the performance of my duties for the Company. Any property situated on the Company’s
premises

 
and owned by the Company, including without limitation computers, disks and other storage media, filing cabinets or other work areas, is subject to inspection by the Company at any time with or
without notice. In the event of the termination of my employment for any reason, I will deliver to the Company all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals,
specification sheets, program listings, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary Information, and other materials of any nature pertaining to the Proprietary Information
of the Company and to my work, and will not take or keep in my possession any of the foregoing or any copies. 
 7.
Enforcement of Intellectual Property Rights. I will cooperate fully with the Company, both during and after my employment with the Company, with respect to the procurement, maintenance and enforcement of Intellectual Property Rights in
Company-Related Developments. I will sign, both during and after the term of this Agreement, all papers, including without limitation copyright applications, patent applications, declarations, oaths, assignments of priority rights, and powers of
attorney, which the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development. If the Company is unable, after reasonable effort, to secure my signature on any such papers, I hereby
irrevocably designate and appoint each officer of the Company as my agent and attorney-in-fact to execute any such papers on my behalf, and to take any and all actions as the Company may deem necessary or desirable in order to protect its rights and
interests in any Company-Related Development. 
 8. Non-Competition and Non-Solicitation. In order to protect
the Company’s Proprietary Information and good will, during my employment and for a period of twelve (12) months following the termination of my employment for any reason (the “Restricted Period”), I will not directly or
indirectly, whether as owner, partner, shareholder, director, manager, consultant, agent, employee, co-venturer or otherwise, engage, participate or invest in any business activity anywhere in the United States that (i) is engaged in the sale,
installation or distribution of GPS Vehicle Tracking Systems then engaged in by the Company, and/or (ii) develops, manufactures or markets any products, or performs any services, that are otherwise competitive with the products or services of
the Company, or products or services that the Company or its affiliates, has under development or that are the subject of active planning at any time during my employment (8(i) and (ii) shall be referred to as the “Company’s
Business”); provided that this shall not prohibit any possible investment in publicly traded stock of a company representing less than one percent of the stock of such company. In addition, during the Restricted Period, I will not, directly or
indirectly, in any manner, other than for the benefit of the Company, (a) call upon, solicit, divert, take away, accept or conduct any business from or with any of the customers or prospective customers of the Company or any of its suppliers if
such activities in competition with the 

 

  
 2 

 
Company’s Business, and/or (b) solicit, entice, attempt to persuade any other employee or consultant of the Company to leave the Company for any reason or otherwise participate in or
facilitate the hire, directly or through another entity, of any person who is employed or engaged by the Company or who was employed or engaged by the Company within six months of any attempt to hire such person. I acknowledge and agree that if I
violate any of the provisions of this paragraph 8, the running of the Restricted Period will be extended by the time during which I engage in such violation(s). For purposes of this Agreement, a “prospective customer” means any potential
customer of the Company which I knew or reasonably should have known that the Company was actively soliciting (other than through a general campaign) or actively considered soliciting (other than through a general campaign) at any time within the
twelve (12) calendar months prior to the last day of my employment. 
 9. Prior Agreements. I hereby
represent that, except as I have fully disclosed previously in writing to the Company, I am not bound by the terms of any agreement with any previous employer or other party to refrain from using or disclosing any trade secret or confidential or
proprietary information in the course of my employment with the Company or to refrain from competing, directly or indirectly, with the business of such previous employer or any other party. I further represent that my performance of all the terms of
this Agreement as an employee of the Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by me in confidence or in trust prior to my employment with the Company. I will not
disclose to the Company or induce the Company to use any confidential or proprietary information or material belonging to any previous employer or others. 
 10. Remedies Upon Breach. I understand that the restrictions contained in this Agreement are necessary for the protection of the business and goodwill of the Company and I consider them to
be reasonable for such purpose. Any breach of this Agreement is likely to cause the Company substantial and irrevocable damage and therefore, in the event of such breach, the Company, in addition to such other remedies which may be available, will
be entitled to specific performance and other injunctive relief, without the posting of a bond. [If I violate this Agreement, in addition to all other remedies available to the Company at law, in equity, and under contract, I agree that I am
obligated to pay all the Company’s costs of enforcement of this Agreement, including attorneys’ fees and expenses.] 

11. [Intentionally Omitted.] 
 12. [Intentionally Omitted.] 
 13. No Employment
Obligation. I understand that this Agreement does not create an obligation on the Company or any other person to continue my employment. I acknowledge that, unless otherwise agreed in a formal written employment agreement signed on behalf of
the Company by an authorized officer, my employment with the Company is at will and therefore may be terminated by the Company or me at any time and for any reason, with or without cause.

 14. Survival and Assignment by the Company. I understand that my
obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment. I further understand that my
obligations under this Agreement will continue following the termination of my employment regardless of the manner of such termination and will be binding upon my heirs, executors and administrators. The Company will have the right to assign this
Agreement to its affiliates, successors and assigns. I expressly consent to be bound by the provisions of this Agreement for the benefit of the Company or any parent, subsidiary or affiliate to whose employ I may be transferred or successor who
assumes my employment agreement with the Company without the necessity that this Agreement be resigned at the time of such transfer or assumption. 
 15. Exit Interview. If and when I depart from the Company, I may be required to attend an exit interview and sign an “Employee Exit Acknowledgement” to reaffirm my acceptance and
acknowledgement of the obligations set forth in this Agreement. For twelve (12) months following termination of my employment, I will notify the Company of any change in my address and of each subsequent employment or business activity,
including the name and address of my employer or other post-Company employment plans and the nature of my activities. 
 16.
Disclosure to Future Employers. During the Restricted Period, I will provide a copy of this Agreement to any prospective employer, partner or coventurer prior to entering into an employment, partnership or other business relationship
with such person or entity. 
 17. Severability. In case any provisions (or portions thereof) contained in this
Agreement shall, for any reason, be held invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such
invalid, illegal or unenforceable provision had never been contained herein. If, moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope,
activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear. 
 18. Interpretation. This Agreement will be deemed to be made and entered into in the Commonwealth of Massachusetts, and will in all respects be interpreted, enforced and governed under the
laws of the Commonwealth of Massachusetts. I hereby agree to consent to personal jurisdiction of the state and federal courts situated within Suffolk County, Massachusetts for purposes of enforcing this Agreement, and waive any objection that I
might have to personal jurisdiction or venue in those courts. 

 

  
 3 

 I UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. BY SIGNING BELOW, I CERTIFY
THAT I HAVE READ IT CAREFULLY AND AM SATISFIED THAT I UNDERSTAND IT COMPLETELY. 
 IN WITNESS WHEREOF, the undersigned has
executed this agreement as a sealed instrument as of the date set forth below. 
  

			
	Signed:	 	  

 

			
	Type or print name:	 	  

 

			
	Date:	 	  

 EXHIBIT 1 

 

			
	To:	 	FleetMatics USA, LLC
		
	From:	 	

			
		
	Date:	 	

  

			
	SUBJECT:	 	Prior Inventions

 The following is a complete list of all inventions or improvements relevant to the subject matter of my
employment by the Company that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company: 
 No inventions or improvements 
 See below: 

 

	
	
	  

	
	  

	
	  

 Additional sheets attached 
 The following is a list of all patents and patent applications in which I have been named as an inventor: 
 None 
 See below: 

 

	
	
	  

	
	  

	
	  

  
 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]